By
Daniel Steyn
Published: Oct. 27, 2023, 7:59 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access
The South African government and pharmaceutical company Johnson & Johnson (J&J) have agreed to a lower price for bedaquiline, a medicine used to treat drug-resistant tuberculosis (DR-TB) in South Africa.
Read More →
By
Daniel Steyn
Published: May 21, 2020, 9:03 p.m.·
Tags:
Global TB response,
Access,
Advocacy
The Stop TB partnership predicts an additional 1.4 million people will die from TB by 2025 thanks to the COVID-19 response.
Read More →
